Tobacco-related carcinogenesis in head and neck cancer Ashok R. JethwaSamir S. Khariwala OriginalPaper 12 August 2017 Pages: 411 - 423
Alcohol and head and neck cancer Daisuke KawakitaKeitaro Matsuo OriginalPaper 16 August 2017 Pages: 425 - 434
Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma Yosuke NakanishiNaohiro WakisakaTomokazu Yoshizaki OriginalPaper Open access 17 August 2017 Pages: 435 - 447
The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma Nicholas FungFarhoud FarajiCarole Fakhry OriginalPaper 15 August 2017 Pages: 449 - 461
EGFR-targeted therapies in the post-genomic era Mary Jue XuDaniel E. JohnsonJennifer R. Grandis OriginalPaper 02 September 2017 Pages: 463 - 473
Checkpoint immunotherapy in head and neck cancers Paul ZolkindRavindra Uppaluri OriginalPaper 23 August 2017 Pages: 475 - 489
mTOR co-targeting strategies for head and neck cancer therapy Zhiyong WangJuan Callejas ValeraJ. Silvio Gutkind OriginalPaper Open access 18 August 2017 Pages: 491 - 502
Targeting metabolic pathways for head and neck cancers therapeutics Masashi YamamotoHidenori InoharaTakashi Nakagawa OriginalPaper 17 August 2017 Pages: 503 - 514
Tumor DNA: an emerging biomarker in head and neck cancer Joseph A. BellairsRifat HasinaNishant Agrawal OriginalPaper 12 August 2017 Pages: 515 - 523
Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma Keiichi KoshizukaToyoyuki HanazawaNaohiko Seki OriginalPaper 23 August 2017 Pages: 525 - 545
Breast cancer complexity: implications of intratumoral heterogeneity in clinical management Brittany HaynesAshapurna SarmaMalathy P. Shekhar NON-THEMATIC REVIEW 27 July 2017 Pages: 547 - 555
